Hospital Provincial de Castellon

Castellon 12002

1 studies enrolling now · 3 studies all time

What they study most

Advanced Breast Cancer, Breast Cancer, Breast Ductal Carcinoma In Situ, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor, Invasive Breast Carcinoma, Metastatic Breast Cancer, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma, Non-small Cell Lung Cancer, PIK3CA Mutation, Synchronous Bilateral Breast Carcinoma

Studies at this site

• Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer — Recruiting now
• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer — Running, not enrolling
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed